glp 1 drug history A Brief of GLP-1 Agonists: From Discovery to Modern GLP-1 Drugs Drop More Than
Description
From an expert perspective, the development of GLP-1RAs has marked a pivotal advancement by targeting key pathophysiological mechanisms such as hepatic lipid metabolism, inflammation, and fibrosis
It is, therefore, important to have liver-specific treatments for patients who have already advanced liver disease
This drug activates GLP-1, GIP and glucagon receptors
The GLP-1R agonist liraglutide increases myocardial glucose oxidation rates via indirect mechanisms and mitigates experimental diabetic cardiomyopathy
Longer-acting formulations with monthly dosing aim to reduce treatment burden and improve adherence
Bacterial components, such as the P9 protein secreted by A
